Ascendis Pharma A/S(ASND) Stock Price Today | Quotes & News - Moomoo

US Stock MarketDetailed Quotes

ASND Ascendis Pharma A/S

Watchlist

166.580
+1.700+1.03%

Close Apr 29 16:00 ET

164.200
-2.380-1.43%

Post 18:32 ET

10.02BMarket Cap-22.33P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Ascendis Pharma A/S | 6-K: Report of foreign private issuer (related to financial reporting)
SEC16:06 ET · Announcements
Earnings Preview: ASND to Report Financial Results Post-market on May 01
Moomoo NewsApr 25 21:00 ET
Ascendis Pharma to Report First Quarter 2025 Financial Results and Provide Business Update on May 1, 2025
GlobeNewswireApr 24 16:01 ET
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Tuesday Trading
MT NewswiresApr 22 11:17 ET
Express News | Ascendis Pharma A/S : RBC Initiates Coverage With Outperform Rating; Price Target $205
ReutersApr 16 02:01 ET
Ascendis Pharma (ASND) Receives a Buy From Evercore ISI
TipRanksApr 14 01:46 ET · Ratings

Comments

DayTradingWithTroy

$Ascendis Pharma A/S (ASND.US)$

Oct 10, 2024 01:29

$Pfizer (PFE.US)$ could see 32$ before the end of tomorrow , keep an eye $GlaxoSmithKline (GSK.US)$ $Summit Therapeutics (SMMT.US)$ $Ascendis Pharma A/S (ASND.US)$

1

Sep 19, 2024 21:28

$Ascendis Pharma A/S (ASND.US)$ big rebound from drop after financials , from 111 to 150. that's a good profit for those who payed attention. $NVIDIA (NVDA.US)$ $Apple (AAPL.US)$

1

Sep 5, 2024 21:46

$Ascendis Pharma A/S (ASND.US)$ reporting wasn't so terrible that it deserves a15% drop. could see this rebounding above the price before the drop

1

Aug 21, 2024 15:00

FDA PDUFA Update…

🚨 This Week’s PDUFAs:
$Regeneron Pharmaceuticals (REGN.US)$ : 🤔
⇨ Linvoseltamab
‣ Multiple myeloma
‣ PDUFA: 8/22/24 (BLA)
🗓️ Last Week’s PDUFAs:
$Gilead Sciences (GILD.US)$ : Approved 8/14 🎉
⇨ Livdelzi (Seladelpar)
‣ Primary biliary cholangitis (PBC)
‣ PDUFA: 8/14/24 (NDA)
$Ascendis Pharma A/S (ASND.US)$ : Approved 8/12 🎉
⇨ YORVIPATH (palopegteriparatide)
‣ Hypoparathyroidism
‣ PDUFA: 8/14/24 (NDA)
$Syndax Pharmaceuticals (SNDX.US)$ & $Incyte (INCY.US)$ : Approved 8/14 🎉
⇨ Nikt...

8

Read more